TELA Bio, Inc. provided revenue guidance for the year 2024. For the year, the company expects Increased full year 2024 revenue guidance to $74.5 million to $76.5 million, representing 27% to 31% year-over-year growth.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.08 USD | -8.30% |
|
-9.77% | -23.26% |
Jun. 04 | TELA Bio, Inc. Appoints Jeffrey Blizard to its Board of Directors | CI |
May. 20 | TELA Bio, Inc. Appoints Greg Firestone as Chief Commercial Officer | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.26% | 125M | |
-3.19% | 105B | |
-4.14% | 67.55B | |
+15.49% | 46.71B | |
-6.00% | 46.39B | |
+4.82% | 40.93B | |
+22.10% | 31.63B | |
+12.18% | 24.28B | |
-8.53% | 23.46B | |
-12.33% | 21.95B |
- Stock Market
- Equities
- TELA Stock
- News TELA Bio, Inc.
- TELA Bio, Inc. Provides Revenue Guidance for the Year 2024